Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Lung Cancer

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 80 articles: HTML format Text format

Single Articles

March 2010
1. MAILLOUX AW , Clark AM, I Young MR
   NK depletion results in increased CCL22 secretion and treg levels in lewis lung carcinoma via the accumulation of CCL22-secreting CD11b(+)CD11c(+) cells.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. NAGANO T , Yasunaga M, Goto K, Kenmotsu H, et al
   Synergistic antitumor activity of the SN-38-incorporating polymeric micelles NK012 with S-1 in a mouse model of Non-small cell lung cancer.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
3. TIMOFEEVA M , Kropp S, Sauter W, Beckmann L, et al
   Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
4. CHETTY C , Lakka SS, Bhoopathi P, Rao JS, et al
   MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells.
   Int J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. LIANG HY , Zhou H, Li XL, Yin ZH, et al
   Chemo-radiotherapy for advanced non-small cell lung cancer: Concurrent or sequential? it's no longer the question: A systematic review.
   Int J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
6. LABRINIDIS A , Hay S, Liapis V, Findlay DM, et al
   Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model.
   Int J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. DUAN W , Gao L, Wu X, Wang L, et al
   MicroRNA-34a is an important component of PRIMA-1 induced apoptotic network in human lung cancer cells.
   Int J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
8. FUCHS P , Loeseken C, Schubert JK, Miekisch W, et al
   Breath gas aldehydes as biomarkers of lung cancer.
   Int J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. FILHO PA , Lopez-Albaitero A, Xi L, Gooding W, et al
   Quantitative expression and immunogenicity of MAGE-3 and -6 in upper aerodigestive tract cancer.
   Int J Cancer. 2009;125:1912-20.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. SALO S , Boutaud A, Hansen AJ, He L, et al
    Antibodies blocking adhesion and matrix binding domains of laminin-332 inhibit tumor growth and metastasis in vivo.
    Int J Cancer. 2009;125:1814-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. WICKERSHEIM A , Kerber M, de Miguel LS, Plate KH, et al
    Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors.
    Int J Cancer. 2009;125:1771-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. KUSAKABE M , Kutomi T, Watanabe K, Emoto N, et al
    Identification of G0S2 as a gene frequently methylated in squamous lung cancer by combination of in silico and experimental approaches.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. MENVIELLE G , Boshuizen H, Kunst AE, Vineis P, et al
    Occupational exposures contribute to educational inequalities in lung cancer incidence among men. evidence from the epic prospective cohort study.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. GADE P , Singh AK, Roy SK, Reddy SP, et al
    Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated dapk1 in human cancers and cancer cells.
    Int J Cancer. 2009;125:1566-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. MURAS AG , Hajj GN, Ribeiro KB, Nomizo R, et al
    Prion protein ablation increases cellular aggregation and embolization contributing to mechanisms of metastasis.
    Int J Cancer. 2009;125:1523-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
16. BUCKINGHAM L , Faber LP, Kim A, Liptay M, et al
    PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II non small cell lung cancer patients.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. IAN BRAY F , Weiderpass E
    Lung cancer mortality trends in 36 European countries: Secular trends and birth cohort patterns by sex and region 1970-2007.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
18. BRINKROLF P , Landmeier S, Altvater B, Chen C, et al
    A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease.
    Int J Cancer. 2009;125:879-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. WANG CK , Chang H, Chen PH, Chang JT, et al
    Aryl hydrocarbon receptor activation and overexpression upregulated fibroblast growth factor-9 in human lung adenocarcinomas.
    Int J Cancer. 2009;125:807-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. SALNIKOV AV , Gladkich J, Moldenhauer G, Volm M, et al
    CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
21. ZHENG YL , Kosti O, Loffredo C, Bowman E, et al
    Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: Genotype and phenotype analyses from a case-control study.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. OWONIKOKO TK , Ramalingam SS, Kanterewicz B, Balius T, et al
    Vorinostat increases carboplatin and paclitaxel activity in non-small cell lung cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. ZHANG W , Liu JN, Tan XY
    Vaccination with xenogeneic tumor endothelial proteins isolated in situ inhibits tumor angiogenesis and spontaneous metastasis.
    Int J Cancer. 2009;125:124-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. PALEARI L , Sessa F, Catassi A, Servent D, et al
    Inhibition of non-neuronal alpha7-nicotinic receptor reduces tumorigenicity in A549 NSCLC xenografts.
    Int J Cancer. 2009;125:199-211.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
25. WU JY , Shih JY, Yang CH, Chen KY, et al
    Second-line treatments after first-line gefitinib therapy in advanced non-small cell lung cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. HE C , Liu M, Zhou C, Zhang J, et al
    Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small cell lung cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. LIANG HY , Li XL, Yu XS, Guan P, et al
    Facts and fiction of the relationship between pre-existing tuberculosis and lung cancer risk: A systematic review.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. BOFFETTA P , Rabkin CS, Gridley G
    A cohort study of cancer among sarcoidosis patients.
    Int J Cancer. 2009;124:2697-700.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
29. YAN L , Zhang D, Chen C, Mao Y, et al
    TP53 Arg72Pro polymorphism and lung cancer risk: A meta-analysis.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. DERBY KS , Cuthrell K, Caberto C, Carmella S, et al
    Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. FUKAZAWA T , Maeda Y, Matsuoka J, Tanaka N, et al
    Drug-regulatable cancer cell death induced by BID under control of the tissue-specific, lung cancer-targeted TTS promoter system.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. KOUSHIK A , Parent ME, Siemiatycki J
    Characteristics of menstruation and pregnancy and the risk of lung cancer in women.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. ZHANG C , Liu Y, Gao Y, Shen J, et al
    Modified heparins inhibit integrin alpha(IIb)beta(3) mediated adhesion of melanoma cells to platelets in vitro and in vivo.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. KLUGE A , Dabir S, Kern J, Nethery D, et al
    Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. JIN G , Miao R, Hu Z, Xu L, et al
    Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population.
    Int J Cancer. 2009;124:2172-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. HONG SH , Briggs J, Newman R, Hoffman K, et al
    Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I.
    Int J Cancer. 2009;124:2042-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
37. YANG L , Yang G, Zhou M, Smith M, et al
    Body mass index and mortality from lung cancer in smokers and nonsmokers: A nationally representative prospective study of 220,000 men in China.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. KUBO T , Yamamoto H, Lockwood WW, Valencia I, et al
    MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.
    Int J Cancer. 2009;124:1778-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. WYSOCZYNSKI M , Ratajczak MZ
    Lung cancer secreted microvesicles: Underappreciated modulators of microenvironment in expanding tumors.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. ZAROGOULIDIS K , Boutsikou E, Zarogoulidis P, Eleftheriadou E, et al
    The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
41. ROTONDO R , Barisione G, Mastracci L, Grossi F, et al
    IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. MCCOLGAN P , Sharma P
    Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. BONNET-DUQUENNOY M , Papon J, Mishellany F, Labarre P, et al
    Targeted radionuclide therapy of melanoma: Anti-tumoural efficacy studies of a new (131)I labelled potential agent.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. MCDONALD B , Spicer J, Giannais B, Fallavollita L, et al
    Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
45. OJI Y , Kitamura Y, Kamino E, Kitano A, et al
    WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. WUTTIG D , Baier B, Fuessel S, Meinhardt M, et al
    Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease-free interval and the number of metastases per patient.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. FALVELLA FS , Frullanti E, Galvan A, Spinola M, et al
    FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
48. GAO Y , Goldstein AM, Consonni D, Pesatori AC, et al
    Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. CHEN YT , Hsu M, Lee P, Shin SJ, et al
    Cancer/testis antigen CT45: Analysis of mRNA and protein expression in human cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. MARTINEZ-BALIBREA E , Martinez-Cardus A, Musulen E, Gines A, et al
    Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. KIM M , Miyamoto S, Yasui Y, Oyama T, et al
    Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice.
    Int J Cancer. 2009;124:264-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. JESS PR , Mazilu M, Dholakia K, Riches AC, et al
    Optical detection and grading of lung neoplasia by Raman microspectroscopy.
    Int J Cancer. 2009;124:376-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. FEDERICI C , Brambilla D, Lozupone F, Matarrese P, et al
    Pleiotropic function of ezrin in human metastatic melanomas.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
54. ZHU H , Glasgow W, George MD, Chrysovergis K, et al
    15-Lipoxygenase-1 activates tumor suppressor p53 independent of enzymatic activity.
    Int J Cancer. 2008;123:2741-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. MORISAWA T , Marusawa H, Ueda Y, Iwai A, et al
    Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression.
    Int J Cancer. 2008;123:2735-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. CHETTY C , Bhoopathi P, Rao JS, Lakka SS, et al
    Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. JIANG SX , Yamashita K, Yamamoto M, Piao CJ, et al
    EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance.
    Int J Cancer. 2008;123:2480-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. D'AGOSTINI F , Balansky R, Steele VE, Ganchev G, et al
    Preneoplastic and neoplastic lesions in the lung, liver and urinary tract of mice exposed to environmental cigarette smoke and UV light since birth.
    Int J Cancer. 2008;123:2497-502.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
59. BERMEJO JL , Sundquist J, Hemminki K
    Sex-specific familial risks of urinary bladder cancer and associated neoplasms in Sweden.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. BROOKS KJ , Coleman EJ, Vitetta ES
    The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines.
    Int J Cancer. 2008;123:2438-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. GALVAN A , Falvella FS, Spinola M, Frullanti E, et al
    A polygenic model with common variants may predict lung adenocarcinoma risk in humans.
    Int J Cancer. 2008;123:2327-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. DENG L , Kimmel M, Foy M, Spitz M, et al
    Estimation of the effects of smoking and DNA repair capacity on coefficients of a carcinogenesis model for lung cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. NEUMEYER-GROMEN A , Razum O, Kersten N, Seidler A, et al
    Diesel motor emissions and lung cancer mortality-Results of the second follow-up of a cohort study in potash miners.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. RIETHDORF S , Wikman H, Pantel K
    Review: Biological relevance of disseminated tumor cells in cancer patients.
    Int J Cancer. 2008;123:1991-2006.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
65. REINMUTH N , Liersch R, Raedel M, Fehrmann F, et al
    Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. TAKESHITA M , Koga T, Takayama K, Kouso H, et al
    CHFR expression is preferentially impaired in smoking-related squamous cell carcinoma of the lung, and the diminished expression significantly harms outcomes.
    Int J Cancer. 2008;123:1623-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. ENGELS EA , Shen M, Chapman RS, Pfeiffer RM, et al
    Tuberculosis and subsequent risk of lung cancer in Xuanwei, China.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
68. DASKALOS A , Nikolaidis G, Xinarianos G, Savvari P, et al
    Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. TANG SJ , Ho MY, Cho HC, Lin YC, et al
    Phosphoglycerate kinase 1-overexpressing lung cancer cells reduce cyclooxygenase 2 expression and promote anti-tumor immunity in vivo.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. MOREAU D , Jacquot C, Tsita P, Chinou I, et al
    Original triazine inductor of new specific molecular targets, with antitumor activity against nonsmall cell lung cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. CHENG YJ , Lee CH, Lin YP, Huang JY, et al
    Caspase-3 enhances lung metastasis and cell migration in a protease-independent mechanism through the ERK pathway.
    Int J Cancer. 2008;123:1278-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. HARAO M , Hirata S, Irie A, Senju S, et al
    HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
73. TAKAHASHI Y , Nishikawa M, Suehara T, Takiguchi N, et al
    Gene silencing of beta-catenin in melanoma cells retards their growth but promotes the formation of pulmonary metastasis in mice.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. MULLER PJ , Dally H, Klappenecker CN, Edler L, et al
    Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. SMITH JS , Kumlin U, Nyberg F, Fortes C, et al
    Lack of association between serum antibodies of Chlamydia pneumoniae infection and the risk of lung cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles   
    
    
    
76. LAN Q , He X, Shen M, Tian L, et al
    Variation in lung cancer risk by smoky coal subtype in Xuanwei, China.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. CHANG JS , Wrensch MR, Hansen HM, Sison JD, et al
    Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
78. CECCARELLI J , Delfino L, Zappia E, Castellani P, et al
    The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. MAATTA AM , Makinen K, Ketola A, Liimatainen T, et al
    Replication competent Semliki Forest virus prolongs survival in experimental lung cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. LEIDINGER P , Keller A, Ludwig N, Rheinheimer S, et al
    Toward an early diagnosis of lung cancer: An autoantibody signature for squamous cell lung carcinoma.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: